Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
Hoon
Dave S B
DS
Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. hoon@jwci.org
D014408:Biomarkers, Tumor / Q000032:analysis*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D014408:Biomarkers, Tumor